DNA topoisomerase I-mediated formation of structurally modified DNA duplexes. Effects of metal ions and topoisomerase I inhibitors

Biochemistry. 1998 Feb 24;37(8):2691-700. doi: 10.1021/bi972707c.

Abstract

The ability of DNA topoisomerase I to mediate the formation of structurally modified DNA duplexes was studied utilizing suicide substrates containing high-efficiency cleavage sites and acceptor oligonucleotides in which the 5'-terminal nucleotides were varied. When the substrates were nicked duplexes, the divalent cations Mg2+ and Ca2+ were found to facilitate the topoisomerase I-mediated formation of ligation products containing 3-nucleotide deletions on the scissile strand, but to suppress the formation of 1-nucleotide deletions. The presence of a complementary nucleotide at the 5'-end of the acceptor strand was not required for the ligation reaction to proceed, but duplex formation to produce duplexes containing a mismatch proceeded more slowly than formation of the fully complementary duplex. Topoisomerase I-mediated mismatch formation in the ligation reaction was inhibited more readily by camptothecin than the corresponding ligation reaction to form a fully complementary duplex; the extent of inhibition was comparable for all three mismatches studied. In comparison, the topoisomerase I inhibitors nitidine and coralyne exhibited quite different effects on the same ligation reactions.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Benzophenanthridines
  • Berberine Alkaloids / pharmacology
  • Binding Sites
  • Calcium / pharmacology
  • Camptothecin / pharmacology
  • Cations, Divalent / pharmacology
  • Cattle
  • DNA / chemistry*
  • DNA / genetics
  • DNA / metabolism*
  • DNA Topoisomerases, Type I / metabolism*
  • Enzyme Inhibitors / pharmacology
  • In Vitro Techniques
  • Kinetics
  • Magnesium / pharmacology
  • Nucleic Acid Conformation
  • Oligodeoxyribonucleotides / chemistry
  • Oligodeoxyribonucleotides / genetics
  • Oligodeoxyribonucleotides / metabolism
  • Phenanthridines / pharmacology
  • Substrate Specificity
  • Topoisomerase I Inhibitors
  • Topotecan / pharmacology

Substances

  • Benzophenanthridines
  • Berberine Alkaloids
  • Cations, Divalent
  • Enzyme Inhibitors
  • Oligodeoxyribonucleotides
  • Phenanthridines
  • Topoisomerase I Inhibitors
  • coralyne
  • Topotecan
  • DNA
  • nitidine
  • DNA Topoisomerases, Type I
  • Magnesium
  • Calcium
  • Camptothecin